药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Troxerutin
The risk or severity of bleeding can be increased when Choline salicylate is combined with Troxerutin.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Dabigatran
The risk or severity of bleeding can be increased when Choline salicylate is combined with Dabigatran.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Edetate calcium disodium anhydrous
The risk or severity of bleeding can be increased when Choline salicylate is combined with Edetate calcium disodium anhydrous.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Tocopherylquinone
The risk or severity of bleeding can be increased when Choline salicylate is combined with Tocopherylquinone.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Saruplase
The risk or severity of bleeding can be increased when Choline salicylate is combined with Saruplase.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Melagatran
The risk or severity of bleeding can be increased when Choline salicylate is combined with Melagatran.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Brinase
The risk or severity of bleeding can be increased when Choline salicylate is combined with Brinase.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Protein S human
The risk or severity of bleeding can be increased when Choline salicylate is combined with Protein S human.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Gabexate
The risk or severity of bleeding can be increased when Choline salicylate is combined with Gabexate.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Monteplase
The risk or severity of bleeding can be increased when Choline salicylate is combined with Monteplase.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Darexaban
The risk or severity of bleeding can be increased when Choline salicylate is combined with Darexaban.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Letaxaban
The risk or severity of bleeding can be increased when Choline salicylate is combined with Letaxaban.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Antithrombin III human
The risk or severity of bleeding can be increased when Choline salicylate is combined with Antithrombin III human.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Protein C
The risk or severity of bleeding can be increased when Choline salicylate is combined with Protein C.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Antithrombin Alfa
The risk or severity of bleeding can be increased when Choline salicylate is combined with Antithrombin Alfa.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Zinc citrate
The risk or severity of bleeding can be increased when Choline salicylate is combined with Zinc citrate.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Desirudin
The risk or severity of bleeding can be increased when Choline salicylate is combined with Desirudin.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Parnaparin
The risk or severity of bleeding can be increased when Choline salicylate is combined with Parnaparin.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Bemiparin
The risk or severity of bleeding can be increased when Choline salicylate is combined with Bemiparin.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Dextran
The risk or severity of bleeding can be increased when Choline salicylate is combined with Dextran.